cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.8085938
title: Small-scale Layered Structures at ICB

description: This data set, published for the manuscript titled "Small-scale Layered Structures at the Inner Core Boundary," comprises PcP and PKiKP observations obtained from the China National Seismic Network (CNSN). These observations were utilized in this study to constrain the structure of the Inner Core Boundary (ICB) beneath Northeast Asia.
DOI: 10.5281/zenodo.8085937
title: Small-scale Layered Structures at ICB

description: This data set, published for the manuscript titled "Small-scale Layered Structures at the Inner Core Boundary," comprises PcP and PKiKP observations obtained from the China National Seismic Network (CNSN). These observations were utilized in this study to constrain the structure of the Inner Core Boundary (ICB) beneath Northeast Asia.
DOI: 10.7910/dvn/t2nf3p
title: Replication Data for: Sovereign Debt

description: Datasets for Sovereignty Debt
DOI: 10.6084/m9.figshare.22590046
title: Sequence alignments for Pseudomys novaehollandiae

description: Processed sequence data to accompany the manuscript "Population genomics of decline and local extinction in the endangered Australian Pookila" Files include: Nuclear exon alignment in nexus format (all_pookila_nuclear_exon_alignment.nex) Whole mitogenome alignment in fasta format (all_pookila_whole_mitogenome_alignment.fasta)
DOI: 10.6084/m9.figshare.22590046.v1
title: Sequence alignments for Pseudomys novaehollandiae

description: Processed sequence data to accompany the manuscript "Population genomics of decline and local extinction in the endangered Australian Pookila" Files include: Nuclear exon alignment in nexus format (all_pookila_nuclear_exon_alignment.nex) Whole mitogenome alignment in fasta format (all_pookila_whole_mitogenome_alignment.fasta)
DOI: 10.5281/zenodo.8058692
title: Supplementary files for "Data-driven estimation of nitric oxide emissions from global soils based on dominant vegetation covers"

description: In-situ observations collected from publications, data-driven model codes, DNDC simulation files, and the supporting data for all figures of this study are uploaded. In-situ observations included 1,356 observations of soil nitric oxide (NO) emissions from 192 sites, including 1,032 for cropland soils from 70 sites, 114 for grassland soils from 36 sites, and 208 for forest soils from 86 sites. Data-driven models provided three machine learning methods, including random forest (RF), generalized boosted regression model (GBM), and radial basis function (RBF). The DNDC simulation files included simulation files of 51 selected sites.
DOI: 10.5281/zenodo.8058693
title: Supplementary files for "Data-driven estimation of nitric oxide emissions from global soils based on dominant vegetation covers"

description: In-situ observations collected from publications, data-driven model codes, and DNDC simulation files of this study are uploaded. In-situ observations included 1,356 observations of soil nitric oxide (NO) emissions from 192 sites, including 1,032 for cropland soils from 70 sites, 114 for grassland soils from 36 sites, and 208 for forest soils from 86 sites. Data-driven models provided three machine learning methods, including random forest (RF), generalized boosted regression model (GBM), and radial basis function (RBF). The DNDC simulation files included simulation files of 51 selected sites.
DOI: 10.5281/zenodo.8086062
title: Supplementary files for "Data-driven estimation of nitric oxide emissions from global soils based on dominant vegetation covers"

description: In-situ observations collected from publications, data-driven model codes, DNDC simulation files, and the supporting data for all figures of this study are uploaded. In-situ observations included 1,356 observations of soil nitric oxide (NO) emissions from 192 sites, including 1,032 for cropland soils from 70 sites, 114 for grassland soils from 36 sites, and 208 for forest soils from 86 sites. Data-driven models provided three machine learning methods, including random forest (RF), generalized boosted regression model (GBM), and radial basis function (RBF). The DNDC simulation files included simulation files of 51 selected sites.
DOI: 10.5517/ccdc.csd.ccwtt3l
title: CCDC 829160: Experimental Crystal Structure Determination

description: Related Article: Yeliz Kaya, Savaş Kaya, Avni Berisha, Ayşe Erçağ|2023|J.Mol.Struct.|1291|135973|doi:10.1016/j.molstruc.2023.135973
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc279csq
title: CCDC 2064593: Experimental Crystal Structure Determination

description: Related Article: Fatma Aydin, N. Burcu Arslan|2022|Molbank|2022|M1316|doi:10.3390/M1316
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2dfcqy
title: CCDC 2217390: Experimental Crystal Structure Determination

description: Related Article: Fatima Klongdee, Kittipong Chainok, Sujittra Youngme, Jaursup Boonmak|2023|CrystEngComm|25|3628|doi:10.1039/D3CE00384A
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2dfcrz
title: CCDC 2217391: Experimental Crystal Structure Determination

description: Related Article: Fatima Klongdee, Kittipong Chainok, Sujittra Youngme, Jaursup Boonmak|2023|CrystEngComm|25|3628|doi:10.1039/D3CE00384A
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2dfcs0
title: CCDC 2217392: Experimental Crystal Structure Determination

description: Related Article: Fatima Klongdee, Kittipong Chainok, Sujittra Youngme, Jaursup Boonmak|2023|CrystEngComm|25|3628|doi:10.1039/D3CE00384A
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2dfct1
title: CCDC 2217393: Experimental Crystal Structure Determination

description: Related Article: Fatima Klongdee, Kittipong Chainok, Sujittra Youngme, Jaursup Boonmak|2023|CrystEngComm|25|3628|doi:10.1039/D3CE00384A
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.23586048
title: Supplementary Material for: Real world outcomes of FLOT vs CROSS regimens for patients with oesophagogastric cancers

description: Introduction: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ) and gastric cancer (GC) includes either neoadjuvant CROSS for OC or GOJ or perioperative FLOT for OC, GOJ and GC adenocarcinoma. This study aims to describe the real-world outcomes of patients with GC, GOJ and OC treated with FLOT or CROSS and identify variables associated with efficacy through exploratory analysis. We also aimed to evaluate the comparison of FLOT and CROSS for the treatment of OC and GOJ adenocarcinomas. Methods: This is a retrospective observational study of patients with locally advanced OC, GOJ or GC treated with FLOT or CROSS between January 2015 to June 2021 in 5 cancer centers across Sydney, Australia. Long-rank test was used to compare survival estimated between subgroups. Hazard ratios for univariate and multivariate analysis were estimated with cox-proportional regression. Results: The study included 168 patients. The 24 month relapse free survival (RFS) and overall survival (OS) for FLOT was 59% and 69% respectively. The median RFS was 29.6 months and median OS was not reached. For CROSS, The 24 month RFS and OS was 55% and 63% with a median RFS and OS of 28.5 and 40.2 months, respectively. There was no difference in OS and RFS between the treatments. FLOT was less tolerable than CROSS with more dose reductions, treatment discontinuation and clinically relevant grade 3 and 4 toxicity. Neutrophil lymphocyte ratio (NLR)) was associated with survival for both treatments. Conclusion: Similar efficacy outcomes were seen in this real world population compared to the clinical trials for FLOT and CROSS.
DOI: 10.6084/m9.figshare.23586051
title: Supplementary Material for: Real world outcomes of FLOT vs CROSS regimens for patients with oesophagogastric cancers

description: Introduction: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ) and gastric cancer (GC) includes either neoadjuvant CROSS for OC or GOJ or perioperative FLOT for OC, GOJ and GC adenocarcinoma. This study aims to describe the real-world outcomes of patients with GC, GOJ and OC treated with FLOT or CROSS and identify variables associated with efficacy through exploratory analysis. We also aimed to evaluate the comparison of FLOT and CROSS for the treatment of OC and GOJ adenocarcinomas. Methods: This is a retrospective observational study of patients with locally advanced OC, GOJ or GC treated with FLOT or CROSS between January 2015 to June 2021 in 5 cancer centers across Sydney, Australia. Long-rank test was used to compare survival estimated between subgroups. Hazard ratios for univariate and multivariate analysis were estimated with cox-proportional regression. Results: The study included 168 patients. The 24 month relapse free survival (RFS) and overall survival (OS) for FLOT was 59% and 69% respectively. The median RFS was 29.6 months and median OS was not reached. For CROSS, The 24 month RFS and OS was 55% and 63% with a median RFS and OS of 28.5 and 40.2 months, respectively. There was no difference in OS and RFS between the treatments. FLOT was less tolerable than CROSS with more dose reductions, treatment discontinuation and clinically relevant grade 3 and 4 toxicity. Neutrophil lymphocyte ratio (NLR)) was associated with survival for both treatments. Conclusion: Similar efficacy outcomes were seen in this real world population compared to the clinical trials for FLOT and CROSS.
DOI: 10.6084/m9.figshare.23586051.v1
title: Supplementary Material for: Real world outcomes of FLOT vs CROSS regimens for patients with oesophagogastric cancers

description: Introduction: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ) and gastric cancer (GC) includes either neoadjuvant CROSS for OC or GOJ or perioperative FLOT for OC, GOJ and GC adenocarcinoma. This study aims to describe the real-world outcomes of patients with GC, GOJ and OC treated with FLOT or CROSS and identify variables associated with efficacy through exploratory analysis. We also aimed to evaluate the comparison of FLOT and CROSS for the treatment of OC and GOJ adenocarcinomas. Methods: This is a retrospective observational study of patients with locally advanced OC, GOJ or GC treated with FLOT or CROSS between January 2015 to June 2021 in 5 cancer centers across Sydney, Australia. Long-rank test was used to compare survival estimated between subgroups. Hazard ratios for univariate and multivariate analysis were estimated with cox-proportional regression. Results: The study included 168 patients. The 24 month relapse free survival (RFS) and overall survival (OS) for FLOT was 59% and 69% respectively. The median RFS was 29.6 months and median OS was not reached. For CROSS, The 24 month RFS and OS was 55% and 63% with a median RFS and OS of 28.5 and 40.2 months, respectively. There was no difference in OS and RFS between the treatments. FLOT was less tolerable than CROSS with more dose reductions, treatment discontinuation and clinically relevant grade 3 and 4 toxicity. Neutrophil lymphocyte ratio (NLR)) was associated with survival for both treatments. Conclusion: Similar efficacy outcomes were seen in this real world population compared to the clinical trials for FLOT and CROSS.
DOI: 10.6084/m9.figshare.23586054
title: Supplementary Material for: Real world outcomes of FLOT vs CROSS regimens for patients with oesophagogastric cancers

description: Introduction: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ) and gastric cancer (GC) includes either neoadjuvant CROSS for OC or GOJ or perioperative FLOT for OC, GOJ and GC adenocarcinoma. This study aims to describe the real-world outcomes of patients with GC, GOJ and OC treated with FLOT or CROSS and identify variables associated with efficacy through exploratory analysis. We also aimed to evaluate the comparison of FLOT and CROSS for the treatment of OC and GOJ adenocarcinomas. Methods: This is a retrospective observational study of patients with locally advanced OC, GOJ or GC treated with FLOT or CROSS between January 2015 to June 2021 in 5 cancer centers across Sydney, Australia. Long-rank test was used to compare survival estimated between subgroups. Hazard ratios for univariate and multivariate analysis were estimated with cox-proportional regression. Results: The study included 168 patients. The 24 month relapse free survival (RFS) and overall survival (OS) for FLOT was 59% and 69% respectively. The median RFS was 29.6 months and median OS was not reached. For CROSS, The 24 month RFS and OS was 55% and 63% with a median RFS and OS of 28.5 and 40.2 months, respectively. There was no difference in OS and RFS between the treatments. FLOT was less tolerable than CROSS with more dose reductions, treatment discontinuation and clinically relevant grade 3 and 4 toxicity. Neutrophil lymphocyte ratio (NLR)) was associated with survival for both treatments. Conclusion: Similar efficacy outcomes were seen in this real world population compared to the clinical trials for FLOT and CROSS.
DOI: 10.6084/m9.figshare.23586054.v1
title: Supplementary Material for: Real world outcomes of FLOT vs CROSS regimens for patients with oesophagogastric cancers

description: Introduction: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ) and gastric cancer (GC) includes either neoadjuvant CROSS for OC or GOJ or perioperative FLOT for OC, GOJ and GC adenocarcinoma. This study aims to describe the real-world outcomes of patients with GC, GOJ and OC treated with FLOT or CROSS and identify variables associated with efficacy through exploratory analysis. We also aimed to evaluate the comparison of FLOT and CROSS for the treatment of OC and GOJ adenocarcinomas. Methods: This is a retrospective observational study of patients with locally advanced OC, GOJ or GC treated with FLOT or CROSS between January 2015 to June 2021 in 5 cancer centers across Sydney, Australia. Long-rank test was used to compare survival estimated between subgroups. Hazard ratios for univariate and multivariate analysis were estimated with cox-proportional regression. Results: The study included 168 patients. The 24 month relapse free survival (RFS) and overall survival (OS) for FLOT was 59% and 69% respectively. The median RFS was 29.6 months and median OS was not reached. For CROSS, The 24 month RFS and OS was 55% and 63% with a median RFS and OS of 28.5 and 40.2 months, respectively. There was no difference in OS and RFS between the treatments. FLOT was less tolerable than CROSS with more dose reductions, treatment discontinuation and clinically relevant grade 3 and 4 toxicity. Neutrophil lymphocyte ratio (NLR)) was associated with survival for both treatments. Conclusion: Similar efficacy outcomes were seen in this real world population compared to the clinical trials for FLOT and CROSS.
DOI: 10.21227/wqe4-c748
title: Identification and Verification Datasets Based on Surface Electromyography

description: 8-channel monopolar sEMG signals were acquired using the device developed by our research group at a sampling rate of 1000 Hz. Medical gel electrodes (CH50B, Shanghai Hanjie Electronic Technology Co., LTD., Shanghai, China) were used for data collection. The position of the electrodes is shown in Fig. 2. The REF electrode was placed on the inner side of the upper big arm near the elbow and the RLD electrode was placed on the outer side of the right upper arm near the elbow. Eight monopolar electrodes were placed on the right forearm. Two rings divide the length of the forearm (from wrist to elbow) evenly into three equal sections. Channels 1-4 were placed evenly on the first ring and the channels 5-8 were placed on the second ring.
DOI: 10.57780/esa-00umb1t
title: RO-C-RPCLAP-2-EXT3-MTP035

description: This data set contains EDITED data from Rosetta RPC-LAP acquired during the ROSETTA EXTENSION 3 MTP035 mission phase. Comet C-G/67P was the primary target. [truncated see actual data for full text]
DOI: 10.57780/esa-04rg77c
title: RO-X-RPCLAP-2-CVP2-EDITED2

description: This data set contains EDITED data from Rosetta RPC-LAP acquired during the COMMISSIONING 2 mission phase where there was no primary target. It contains uncalibrated raw data i.e. the digital output of the instrument. [truncated see actual data for full text]
DOI: 10.57780/esa-08jwoi5
title: RO-A-CAL-ALICE-2-AST2

description: This data set contains CODMAC level 2 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the Lutetia flyby mission phase which took place between 2010-06-07 and 2010-09-10. [truncated see actual data for full text]
DOI: 10.57780/esa-0b4yw43
title: RO-A-RPCLAP-2-AST2-EDITED

description: This dataset contains EDITED raw data from Rosetta RPC-LAP acquired during the flyby of asteroid 21 Lutetia. [truncated see actual data for full text]
DOI: 10.57780/esa-0coaa0m
title: RO-CAL-E-ALICE-3-EAR2

description: This data set contains CODMAC level 3 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the second earth swing-by phase of the Rosetta mission which occurred 2007-09-13 to 2007-12-13. In addition to the second swingby of the earth this period includes the active payload checkout #6 (PC6). The observations made during the period covered by this data set are primarily designed to improve the calibration of the Alice instrument. [truncated see actual data for full text]
DOI: 10.57780/esa-0pq9iky
title: RO-C_CAL-ALICE-3-ESC1

description: This data set contains CODMAC Level 3 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the comet 67P/Churyumov-Gerasimenko Comet Escort 1 mission phase which took place between 2014-11-20 and 2015-03-10. The current V3.0 data set supersedes the previous V2.0 data set with improved documentation. [truncated see actual data for full text]
DOI: 10.57780/esa-0pv1ycj
title: RO_ALICE_2_EXT3

description: This data set contains CODMAC Level 2 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the comet 67P/Churyumov-Gerasimenko Rosetta Extension 3 mission phase which took place between 2016-07-01 and 2016-09-30. [truncated see actual data for full text]
DOI: 10.57780/esa-0qxv3cz
title: RO-A-CAL-ALICE-4-AST1

description: This data set contains CODMAC level 4 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the fly-by of the asteroid (2867) Steins which occurred on 2008-09-05. [truncated see actual data for full text]
DOI: 10.57780/esa-0r9ytwx
title: RO-SS-RPCLAP-3-CR4B-CALIB2

description: This data set contains CALIBRATED data from Rosetta RPC-LAP acquired during the CRUISE 4-2 mission phase where the primary target was the SOLAR WIND. It contains instrument outputs in volts and amperes calibrated and corrected for instrument offsets. [truncated see actual data for full text]
DOI: 10.57780/esa-0rzuo7c
title: RO-C-RPCMAG-3-ESC2-CALIBRATED

description: This dataset contains CALIBRATED (CODMAC LEVEL 3) DATA of the COMET ESCORT 2 Phase from March 11 2015 until June 30 2015 of the ROSETTA orbiter magnetometer RPCMAG. Observations are done in the vicinity of comet 67P/CHURYUMOV-GERASIMENKO 1 (1969 R1). The current version of the dataset is V9.0. The difference to the datasets of earlier versions is mainly a significantly improved sensor temperature model more detailed documentation about magnetic disturbance sources more data handling information for the user and also an improved quality flagging system. [truncated see actual data for full text]
DOI: 10.57780/esa-0yxbtq6
title: RO-C-RPCLAP-2-ESC1-EDITED2

description: This data set contains EDITED data from Rosetta RPC-LAP acquired during the COMET ESCORT 1 mission phase where the primary target was the comet 67P/CHURYUMOV-GERASIMENKO 1 (1969 R1). It contains uncalibrated raw data i.e. the digital output of the instrument. This version reorganizes the data into fewer files with longer time series and sorted by type of measurement. It also supersedes previous versions that were split into MTPs. The version number starts over from V1.0 due to a change in naming convention. [truncated see actual data for full text]
DOI: 10.57780/esa-1143uwv
title: RO-C-RPCLAP-5-PRL-DERIV2

description: This data set contains DERIVED data from Rosetta RPC-LAP acquired during the PRELANDING mission phase where the primary target was the comet 67P/CHURYUMOV-GERASIMENKO 1 (1969 R1). It contains high-level data products in physical units such as electron density electron temperature spacecraft potential and downsampled time series of current and voltage measurements. [truncated see actual data for full text]
DOI: 10.57780/esa-11593j7
title: RO_ALICE_2_PRL

description: This data set contains CODMAC Level 2 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the comet 67P/Churyumov-Gerasimenko Prelanding mission phase which took place between 2014-01-21 and 2014-11-19. The current V2.0 data set supersedes the previous V1.0 data set. Pixel list data files have had corrections applied to their FITS formatting. [truncated see actual data for full text]
DOI: 10.57780/esa-11cvwev
title: RO-E-RPCLAP-3-EAR2-CALIB2

description: This data set contains CALIBRATED data from Rosetta RPC-LAP acquired during the EARTH SWING-BY 2 mission phase where the primary target was the planet EARTH. It contains instrument outputs in volts and amperes calibrated and corrected for instrument offsets. [truncated see actual data for full text]
DOI: 10.57780/esa-1624nv3
title: RO_ALICE_3_EXT2

description: This data set contains CODMAC Level 3 data acquired by the Rosetta Orbiter ALICE UV Spectrometer during the comet 67P/Churyumov-Gerasimenko Rosetta Extension 2 mission phase which took place between 2016-04-06 and 2016-06-30. [truncated see actual data for full text]
DOI: 10.57780/esa-18js3c7
title: RO-C-RPCLAP-2-ESC2-MTP014

description: This data set contains EDITED data from Rosetta RPC-LAP acquired during the COMET ESCORT 2 MTP014 mission phase. Comet C-G/67P was the primary target. This data set supersedes RO-C-RPCLAP-2-ESC2-MTP014-V1.0. [truncated see actual data for full text]